Compare DexCom, Inc. (DXCM) vs Fabrinet (FN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Fabrinet — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while Fabrinet trades at $555 (market cap $18.84B). The key difference: DexCom, Inc. is the larger of the two by market cap, and DexCom, Inc. is trading nearer its 52-week high, Fabrinet nearer its low. Which is the better fit depends on your goals.
| DXCM | FN | |
|---|---|---|
Market Cap | $33.79B | $18.84B |
Sector | Health | Technology |
52-Week High | $89.53 | $746.47 |
52-Week Low | $54.84 | $277.04 |
Enterprise Value | $33.24B | $17.90B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Fabrinet
Fabrinet provides advanced optical and electromechanical manufacturing services to original equipment manufacturers. It specializes in complex products for telecom, automotive, and medical industries.
Read more on FN →
